When to Control Endemic Infections by Focusing on High-Risk Groups
- 1 September 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Epidemiology
- Vol. 16 (5) , 621-627
- https://doi.org/10.1097/01.ede.0000172133.46385.18
Abstract
For nontransmissible diseases, decisions between interventions focused on high-risk groups and unfocused interventions can be based on attributable-risk calculations. The assumptions of those calculations, however, are violated for infectious diseases. We used deterministic compartmental models of infection transmission having both high- and low-risk groups and both susceptible and infected states to examine intervention effects on endemic infection levels. High risk is generated by increased susceptibility or contagiousness—factors that can be reduced by interventions. Population effects of focused and unfocused interventions are compared at settings where these would be equal if there were no transmission. In the most likely range of mixing between high- and low-risk groups, focused interventions have considerably larger effects than unfocused interventions. At all mixing levels, both interventions have greater effects on infectious than noninfectious diseases because a change in risk factor for one individual alters risk in others. Interventions on contagiousness in high-risk groups have greater effects than comparable interventions on susceptibility. Risk assessment for infectious disease requires analysis of the population system that is circulating the infection. Vaccine trials on individuals will miss important effects that trials on transmission units will detect. Focusing HIV control on contagiousness factors in high-risk groups will be especially productive.Keywords
This publication has 15 references indexed in Scilit:
- Modeling Infection TransmissionAnnual Review of Public Health, 2004
- Using Validation Sets for Outcomes and Exposure to Infection in Vaccine Field StudiesAmerican Journal of Epidemiology, 2001
- Efficiency of Estimating Vaccine Efficacy for Susceptibility and Infectiousness: Randomization by Individual Versus HouseholdBiometrics, 1999
- Design and Interpretation of Vaccine Field StudiesEpidemiologic Reviews, 1999
- Simulations to Evaluate HIV Vaccine Trial DesignsSIMULATION, 1998
- Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populationsStatistics in Medicine, 1998
- Augmented HIV vaccine trial design for estimating reduction in infectiousness and protective efficacyStatistics in Medicine, 1998
- Study Designs for Evaluating Different Efficacy and Effectiveness Aspects of VaccinesAmerican Journal of Epidemiology, 1997
- The Role of Early HIV Infection in the Spread of HIV Through PopulationsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Measuring Vaccine Efficacy for Both Susceptibility to Infection and Reduction in Infectiousness for Prophylactic HIV-1 VaccinesJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996